 CAMBRIDGE, Mass., Jan. 03, 2022 GLOBE NEWSWIRE -- Oncorus, Inc. NASDAQ: ONCR, a viral immunotherapies company focused on driving innovation to transform outcomes for cancer patients, today announced that President and Chief Executive Officer, Theodore Ted Ashburn, M.D., Ph.D., will participate in a fireside chat at the H.C. Wainwright BioConnect Conference. 